Welcome to the Utah Chapter of the American College of Cardiology
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Patients With Physicians Receiving Industry Payments More Likely to Be Prescribed PCSK9is, ARNi | NCDR StudyPatients with atherosclerotic cardiovascular disease (ASCVD) or heart failure with reduced ejection fraction (HFrEF) were more likely to be prescribed PCSK9 inhibitors or an angiotensin receptor-neprilysin inhibitor (ARNi), respectively, if their physicians received industry payments, according to a recent study published in the American Heart Journal.
- Message From the President: Momentum, Innovation and What’s Ahead For 2026Read a message from ACC President Christopher Kramer, MD, FACC on Momentum, Innovation and What’s Ahead For 2026.
- ACC Announces 2026 Distinguished Award RecipientsThe ACC is pleased to announce the recipients of its 2026 Distinguished Awards. This year's honorees represent an exceptional group of individuals whose past and ongoing efforts have made meaningful contributions to advancing the College's Vision of a world where science, knowledge and innovation improve cardiovascular care and patient outcomes worldwide.
- Low Operator Volume Associated With Worse TAVR, MTEER Outcomes | NCDR StudyLow operator volume was associated with worse 30-day outcomes among patients undergoing TAVR and mitral transcatheter edge-to-edge repair (MTEER), according to a study published Jan. 8 in JAMA Cardiology.
- FINEARTS-HF Analyses Investigate Finerenone and Hypotension, CV Outcomes According to Baseline Kidney FunctionFinerenone was associated with higher rates of post-baseline systolic blood pressure (SBP)